BMAL1 and neoplasm: Moreover, Bu et al. have discovered that the UPR inhibits BMAL1 in Burkitt lymphoma, thereby affecting circadian rhythm and protein synthesis, and promoting tumor progression, which may be associated with the continual activation of c-myc.